What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
No co-sponsors yet.
History
- Print number 5591b
- Amend and recommit to higher education
- Print number 5591a
- Amend (t) and recommit to higher education
- Referred to higher education
- Reported and committed to finance
- Referred to higher education
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Restricts retail sale of ipecac syrup to behind the pharmacy counter or under manager control
In Senate Committee · Higher Education · Sponsor Sam Hoyt
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
BILL NUMBER:S5591B
Title of bill
An act to amend the general business law, in relation to restricting access to ipecac syrup
Purpose
To restrict the access to retail sale of ipecac.
Summary of provisions
Section 1 amends the general business law by adding a new section 39l-q which restricts the access to retail sale of ipecac.
Justification
Ipecac syrup has long been distributed for emergency use to induce vomiting in poisoning cases. Recent years have seen an increase in ipecac abuse among sufferers of bulimia, anorexia and binge eating disorder. While ipecac is often effective in inducing emesis and decreasing the absorption of poisonous toxins, its side effects and abuse potential offer cause for concern.
Repeated use and abuse of ipecac syrup has been linked to skin conditions, cardiac and skeletal muscle weakness, and electrolyte imbalance, with sometimes fatal results. An emerging consensus among many professional medical groups is that syrup of ipecac should no longer be used routinely as a poison treatment in the home. U.S.A. poison centers have also markedly reduced their use of ipecac syrup over the previous decade and, on June 12, 2003, the Food and Drug Administration's Non-prescription Drugs Advisory Committee recommended by a vote of six to four that the FDA rescind ipecac's over-the-counter status.
This legislation seeks to regulate the availability of, and access to, this noxious powerful emetic.
Legislative history
2009-10: A.544-A Passed Assembly 2007-08: A.3913 Reported and Referred to Codes 2005-06: A.3182-A Reported and Referred to Codes 2003-04: A.9954 Held for Consideration in Health; S.6896 - Reported and Committed to Rules
Fiscal implications
None to the State.
Effective date
This act shall take effect immediately; provided, however, that the rules and regulations necessary to implement section one of this act shall be promulgated and take effect on or before the one hundred eightieth day after this act shall have become law.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.